3 Products Including Daiichi Sankyo’s Calblock Classified as Category I

December 4, 2012
Three products including Daiichi Sankyo’s hypertension treatment Calblock Tablets 8 mg/16 mg (azelnidipine) were classified as Category I (recognized useful as approved), based on the results of reexaminations, at a meeting of the Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC)...read more